Login / Signup
Cost-effectiveness of rivaroxaban compared with enoxaparin plus warfarin for the treatment of hospitalised acute deep vein thrombosis in China.
Li Yang
Jingjing Wu
Published in:
BMJ open (2020)
NCT00440193; Post-results.
Keyphrases
</>
venous thromboembolism
atrial fibrillation
direct oral anticoagulants
liver failure
pulmonary embolism
respiratory failure
drug induced
combination therapy
intensive care unit
oral anticoagulants
extracorporeal membrane oxygenation
community acquired pneumonia
mechanical ventilation